Prediction models for breast cancer prognosis among Asian women
暂无分享,去创建一个
X. Shu | H. Cai | Y. Shyr | K. Gu | Fei Ye | S. Nechuta | P. Bao | Liang Shi | Run Fan | Yufan Chen | H. Cai
[1] Gretchen L. Gierach,et al. Association of Circulating Progesterone With Breast Cancer Risk Among Postmenopausal Women , 2020, JAMA network open.
[2] A. Jemal,et al. Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.
[3] C. Friedenreich,et al. Physical Activity in Cancer Prevention and Survival: A Systematic Review , 2019, Medicine and science in sports and exercise.
[4] S. Tin Tin,et al. Prognostic models for breast cancer: a systematic review , 2019, BMC Cancer.
[5] J. Wyatt,et al. Independent validation of the PREDICT breast cancer prognosis prediction tool in 45,789 patients using Scottish Cancer Registry data , 2018, British Journal of Cancer.
[6] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[7] Greta M. Massetti,et al. Weight management and physical activity throughout the cancer care continuum , 2017, CA: a cancer journal for clinicians.
[8] Hua Zhao,et al. Personalized Prognostic Prediction Models for Breast Cancer Recurrence and Survival Incorporating Multidimensional Data , 2017, Journal of the National Cancer Institute.
[9] P. Goodwin,et al. Obesity and Breast Cancer Prognosis: Evidence, Challenges, and Opportunities. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] H. Muss,et al. Internet tools to enhance breast cancer care , 2016, npj Breast Cancer.
[11] James E. Helmreich. Regression Modeling Strategies with Applications to Linear Models, Logistic and Ordinal Regression and Survival Analysis (2nd Edition) , 2016 .
[12] X. Shu,et al. Dietary isoflavones, urinary isoflavonoids, and risk of ischemic stroke in women. , 2015, The American journal of clinical nutrition.
[13] A. McTiernan,et al. Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.
[14] Yanhua Rao,et al. Association between Soy Isoflavone Intake and Breast Cancer Risk for Pre- and Post-Menopausal Women: A Meta-Analysis of Epidemiological Studies , 2014, PloS one.
[15] J. Coffey,et al. Correlation between Nottingham Prognostic Index and Adjuvant! Online prognostic tools in patients with early-stage breast cancer in Mid-Western Ireland. , 2013, Clinical breast cancer.
[16] S. Cross,et al. PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2 , 2012, British Journal of Cancer.
[17] H. Verkooijen,et al. Adjuvant! Online is overoptimistic in predicting survival of Asian breast cancer patients. , 2012, European journal of cancer.
[18] M. J. van de Vijver,et al. UvA-DARE ( Digital Academic Repository ) External Validation of Adjuvant ! Online Breast Cancer Prognosis Tool Prioritising Recommendations for Improvement , 2012 .
[19] David R Bassett,et al. 2011 Compendium of Physical Activities: a second update of codes and MET values. , 2011, Medicine and science in sports and exercise.
[20] P. V. van Diest,et al. In patients younger than age 55 years with lymph node-negative breast cancer, proliferation by mitotic activity index is prognostically superior to adjuvant! , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] M. Coory,et al. Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis , 2010, Breast Cancer Research and Treatment.
[22] X. Shu,et al. Obesity and weight change in relation to breast cancer survival , 2010, Breast Cancer Research and Treatment.
[23] Carlos Caldas,et al. PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer , 2010, Breast Cancer Research.
[24] X. Shu,et al. Soy food intake and breast cancer survival. , 2009, JAMA.
[25] S. Mook,et al. Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study. , 2009, The Lancet. Oncology.
[26] A. Harris,et al. An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom , 2009, British Journal of Cancer.
[27] David W. Hosmer,et al. Applied Survival Analysis: Regression Modeling of Time-to-Event Data , 2008 .
[28] G. Ball,et al. Reading the prognosis of the individual with breast cancer. , 2007, European journal of cancer.
[29] A. Carmichael,et al. Obesity and prognosis of breast cancer , 2006, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[30] Y Wang,et al. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.
[31] Karen A Gelmon,et al. Population-based validation of the prognostic model ADJUVANT! for early breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] B. Rosner,et al. Weight, weight gain, and survival after breast cancer diagnosis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] A. McTiernan,et al. Weight loss in breast cancer patient management. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] S. Akashi-Tanaka,et al. Validation and problems of St-Gallen recommendations of adjuvant therapy for node-negative invasive breast cancer in Japanese patients. , 2001, Japanese journal of clinical oncology.
[35] P. Ravdin,et al. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] K. Covinsky,et al. Assessing the Generalizability of Prognostic Information , 1999, Annals of Internal Medicine.
[37] E. Winer,et al. Weight gain in women diagnosed with breast cancer. , 1997, Journal of the American Dietetic Association.
[38] Lawrence T. Post,et al. American College of Surgeons , 2020, Definitions.
[39] R. Kraft Rovere,et al. Adjuvant! Online: mind the gap! , 2013, Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti.
[40] Nutrition and physical activity guidelines for cancer survivors , 2012, CA: a cancer journal for clinicians.
[41] I. Ellis,et al. The Nottingham prognostic index in primary breast cancer , 2005, Breast Cancer Research and Treatment.
[42] Sten Thorstenson,et al. Applying the Nottingham Prognostic Index to a Swedish breast cancer population , 2004, Breast Cancer Research and Treatment.
[43] C. Axelsson,et al. The Nottingham Prognostic Index applied to 9,149 patients from the studies of the Danish Breast Cancer Cooperative Group (DBCG) , 2004, Breast Cancer Research and Treatment.
[44] B. Hoffman,et al. Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.